Challenges for Rebuilding Trust in the CDC
(Secretary Kennedy) has promised to restore public trust in the CDC, but our polling data suggests real challenges given how skeptical the public - and Republicans in particular - are about the agency.
Quick Takes - Timely insights and analysis from KFF staff
Filter
-
-
Halting mRNA Research Could Deepen the Public’s Distrust and Uncertainty about Vaccine Safety – with Potential Consequences
As the debate over mRNA technology continues, public uncertainty about its safety is likely to persist and may even deepen the partisan divide... as well as hinder any efforts to develop new vaccines in response to future pandemics
-
The Trump Administration is Reducing Enhanced Support for the Part D Stand-Alone Drug Plan Market
In announcing these changes, CMS states that it is “facilitating the Part D program’s return to operating under regular market conditions.” Increasingly, however, these regular conditions appear unfavorable to the ongoing stability of the stand-alone prescription drug plan market, further tilting the playing field towards Medicare Advantage.
-
Planned Parenthood Remains in Limbo as Court Reviews Their Request to Block Federal Medicaid Funding Ban
It's not known when the court will issue an order on Planned Parenthood’s request for a more extensive preliminary injunction. Meanwhile, most Planned Parenthood clinics will not be able to receive federal Medicaid funding for non-abortion services…provided to Medicaid patients.
-
Polling on Medical Debt Illustrates the Challenges that Blocked Credit Reporting Rule Sought to Address
The impact of medical debt on credit scores often has a cascading effect….Adults with health care debt from KFF’s Health Care Debt Survey cited a range of negative outcomes from trouble qualifying for loans to homelessness.
-
Eliquis’s New Lower Direct-to-Consumer Price is Still Higher Than Medicare’s Negotiated Price
Voluntary efforts by drug companies to lower prices on selected medications, such as this new discounted price for Eliquis and previous price reductions on certain insulin products, could expand access to lower-priced drugs for some patients, but are not likely to improve prescription drug affordability in the U.S. on a widespread basis.
-
State Waivers for Continuous Medicaid Eligibility to End Under CMS Guidance
CMS released guidance for states that would end waivers allowing continuous Medicaid eligibility for children and adults. Ending continuous eligibility will increase disenrollment, but not all who lose coverage are no longer eligible… more
-
Senate Reconciliation Bill Would Reduce Federal Medicaid Spending by Over $200 Billion More Than the House Bill
All states and the District of Columbia will lose more federal Medicaid funding under the Senate-passed bill than under the House-passed bill. In 14 states, the Senate bill would reduce federal Medicaid spending by at least $5 billion more than the House bill would have.
-
About 17 Million More People Could be Uninsured due to the Big Beautiful Bill and other Policy Changes
In total, due to the One Big Beautiful Bill Act and other policy changes, the number of people without health insurance is expected to increase by about 17 million. If all of this comes to pass, it would represent the biggest roll back of health insurance coverage ever due to federal policy changes.
-
Policy Uncertainty is Creating Challenges for ACA Marketplace Insurers
Until Congress passes the reconciliation bill, Marketplace insurers will face uncertainty regarding the regulatory landscape and may find it difficult to set premiums for 2026.
